BDBM184627 US9156810, (46, 47)::US9156810, 46/47

SMILES CC1(C)[C@@H](O)[C@H](\C=C\C(O)Cc2ccccc2)[C@@H](C\C=C/CCCC(O)=O)C1=O

InChI Key InChIKey=BHGLRNRVCYDAJB-PGLZQVPMSA-N

Data  7 IC50  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 7 hits for monomerid = 184627   

TargetProstaglandin E2 receptor EP1 subtype(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM184627(US9156810, (46, 47) | US9156810, 46/47)
Affinity DataIC50:  290nMpH: 7.4 T: 2°CAssay Description:HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bot...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin E2 receptor EP1 subtype(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM184627(US9156810, (46, 47) | US9156810, 46/47)
Affinity DataIC50:  963nMpH: 7.4 T: 2°CAssay Description:HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bot...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM184627(US9156810, (46, 47) | US9156810, 46/47)
Affinity DataIC50: >1.00E+4nMpH: 7.4 T: 2°CAssay Description:HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bot...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM184627(US9156810, (46, 47) | US9156810, 46/47)
Affinity DataIC50:  76nMpH: 7.4 T: 2°CAssay Description:HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bot...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDimer of Prostaglandin E2 receptor EP3 subtype(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM184627(US9156810, (46, 47) | US9156810, 46/47)
Affinity DataIC50: >1.00E+4nMpH: 7.4 T: 2°CAssay Description:HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bot...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM184627(US9156810, (46, 47) | US9156810, 46/47)
Affinity DataIC50:  4nM EC50:  0.400nMpH: 7.4 T: 2°CAssay Description:HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bot...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDimer of Prostaglandin E2 receptor EP3 subtype(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM184627(US9156810, (46, 47) | US9156810, 46/47)
Affinity DataIC50: >1.00E+4nM EC50:  589nMpH: 7.4 T: 2°CAssay Description:HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bot...More data for this Ligand-Target Pair
In DepthDetails US Patent